From Medscape Dermatology

Coverage from the

Conference of the European Hidradenitis Suppurativa Foundation (EHSF) 2019

February 06 - 08, 2019; Wrocław, Poland

February 06 - 08, 2019 Wrocław, Poland
  • EHSF 2019 Painful Inflamed Skin Helped With Stronger Drug Dosing Doubling the standard treatment dose in some patients was effective, prompted no adverse effects, and afforded an alternative to other second line therapies, a small case series suggests.
  • EHSF 2019 Methotrexate Added to Biologic Eases Inflamed Skin The combination of methotrexate and anti-TNF therapy can improve clinical response in patients with severe hidradenitis suppurativa, first results from a new study demonstrate.

Conference News

Popular Hidradenitis Suppurativa News

Medscape Dermatology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage